Trial intelligence / Profile preview

Benzocaine patch versus benzocaine gel for pain reduction during intraoral dental injection

IRCT20230125057218N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Nov 2023
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, open-label trial of benzocaine, lidocaine and epinephrine in None (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Amount of pain. Started Nov 2023; status: completed.

02

Drugs

benzocainelidocaineepinephrine

Beyond the preview

Go deeper on IRCT20230125057218N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230125057218N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call